Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Blumenthal

Showing results (91-100 of 233) with videos related to

Pageof 24
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2018
The Impact of a Reported Penicillin Allergy on Surgical Site Infection RiskKimberly G Blumenthal, Erin E Ryan, Yu Li, et al.
JAMA Dermatology|November 2, 2022
Risk Factors for Vancomycin Drug Reaction With Eosinophilia and Systemic Symptoms SyndromeKimberly G Blumenthal, Santiago Alvarez-Arango, Xiaoqing Fu, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 4, 2018
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Identified in the Electronic Health Record Allergy ModuleAnna R Wolfson, Li Zhou, Yu Li, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 15, 2014
Effect of a drug allergy educational program and antibiotic prescribing guideline on inpatient clinical providers' antibiotic prescribing knowledgeKimberly G Blumenthal, Erica S Shenoy, Shelley Hurwitz, et al.
Oncogene|November 9, 2004
Ets1 is an effector of protein kinase Calpha in cancer cellsMartina Vetter, Sibylle G Blumenthal, Ralph K Lindemann, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 23, 2017
Adverse and Hypersensitivity Reactions to Prescription Nonsteroidal Anti-Inflammatory Agents in a Large Health Care SystemKimberly G Blumenthal, Kenneth H Lai, Mingshu Huang, et al.
Frontiers in Medicine|October 2, 2025
Utilizing group-based models to identify adverse event patterns after an interventionWei Wang, Sara Abbaspour, Kimberly G Blumenthal, et al.
ACR Open Rheumatology|April 22, 2020
Increasing Operational Capacity and Reducing Costs of Rituximab Administration: A Costing AnalysisZachary S Wallace, Tyler Harkness, Kimberly G Blumenthal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 15, 2020
Reply to Bland and JonesChristian M Mancini, Kristi Kuper, Lucas T Schulz, et al.
JAAD Case Reports|November 18, 2024
Clinical manifestations of drug reaction with eosinophilia and systemic symptoms in pediatric patientsSuzanne Blackley, Chantal Lemoine-Soto, Li Zhou, et al.
Pageof 24

Showing results (91-100 of 233) with videos related to

Sort By:
Pageof 24
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2018
The Impact of a Reported Penicillin Allergy on Surgical Site Infection RiskKimberly G Blumenthal, Erin E Ryan, Yu Li, et al.
JAMA Dermatology|November 2, 2022
Risk Factors for Vancomycin Drug Reaction With Eosinophilia and Systemic Symptoms SyndromeKimberly G Blumenthal, Santiago Alvarez-Arango, Xiaoqing Fu, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 4, 2018
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Identified in the Electronic Health Record Allergy ModuleAnna R Wolfson, Li Zhou, Yu Li, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 15, 2014
Effect of a drug allergy educational program and antibiotic prescribing guideline on inpatient clinical providers' antibiotic prescribing knowledgeKimberly G Blumenthal, Erica S Shenoy, Shelley Hurwitz, et al.
Oncogene|November 9, 2004
Ets1 is an effector of protein kinase Calpha in cancer cellsMartina Vetter, Sibylle G Blumenthal, Ralph K Lindemann, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 23, 2017
Adverse and Hypersensitivity Reactions to Prescription Nonsteroidal Anti-Inflammatory Agents in a Large Health Care SystemKimberly G Blumenthal, Kenneth H Lai, Mingshu Huang, et al.
Frontiers in Medicine|October 2, 2025
Utilizing group-based models to identify adverse event patterns after an interventionWei Wang, Sara Abbaspour, Kimberly G Blumenthal, et al.
ACR Open Rheumatology|April 22, 2020
Increasing Operational Capacity and Reducing Costs of Rituximab Administration: A Costing AnalysisZachary S Wallace, Tyler Harkness, Kimberly G Blumenthal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 15, 2020
Reply to Bland and JonesChristian M Mancini, Kristi Kuper, Lucas T Schulz, et al.
JAAD Case Reports|November 18, 2024
Clinical manifestations of drug reaction with eosinophilia and systemic symptoms in pediatric patientsSuzanne Blackley, Chantal Lemoine-Soto, Li Zhou, et al.
Pageof 24